Home › Hyperacusis › District of Columbia
Hyperacusis clinical trials in District of Columbia
3 studies for Hyperacusis are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Velocity Clinical Research, Washington DC, Washington D.C.
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 28, 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's National Medical Center, Washington D.C.
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's National Medical Center, Washington D.C.
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.